Clinical observation of Xiaodian Tongluo Recipe in the treatment of recurrent skin allergic purpura in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005247

Enrollment

Unknown

Registered

2021-08-28

Start date

2021-09-15

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Henoch-Schonlein Purpura

Interventions

TCM group:Xiaodian Tongluo Recipe

control group:Chinese medicine simulant + loratadine + vitamin C + prednisone tablets

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Meet the inclusion criteria of recurrent Henoch Schonlein purpura; 2) Rash score = 14; 3) The syndrome differentiation of traditional Chinese medicine belongs to reckless behavior of blood heat; 4) 2 weeks = course = 1 year; 5) 3 = 16 years old; 6) The children and their families agreed and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Accompanied by other intractable allergic diseases, such as intractable urticaria or eczema; 2) Accompanied by severe gastrointestinal symptoms or renal injury; 3) Combined with other organ damage or accompanied by mental, nervous system and hematopoietic system diseases.

Design outcomes

Primary

Measure	Time frame
Rash efficacy;	—

Secondary

Measure	Time frame
Six immune items;urinalysis;liver function;renal function;routine blood test;	—

Countries

China

Contacts

Public ContactHanShanshan

15093292672@163.com15093292672

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026